Chime Biologics
PrivateLast Round
Series A
Extension
Mar 25, 2021
Total Funding Raised
$190M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Chime Biologics is a biotechnology company that provides comprehensive contract development and manufacturing organization (CDMO) services for biologics, supporting clients from early-stage development to commercial production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chime Biologics Comparables
Compare Chime Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Canton Biologics | 93% | |
| Bioworkshops | 89% | |
| Zencore Biologics | 88% |
Chime Biologics Funding Rounds
Historical fundraising activity
Chime Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VMS Group | Series A Extension |
| Fidelity International | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 34% MoM, reaching 2.9K.
- Jun 17, 2026
Monthly visitors grew 105% MoM, reaching 1.7K.
Recent news
Latest coverage and updates
- attends_eventOct 1, 2026
Chime Biologics attends CPHI Milan 2026 in Italy in Oct '26 and highlights three strategic capabilities: Genuine in Dual Source, Megafactory Redefining Biomanufacturing, and Pioneer in Biosimilar.
- partners_withOct 1, 2026
Chime Biologics and Rezon Bio formally announce a strategic collaboration in 2026 that connects manufacturing capabilities in China and Europe to support greater flexibility and supply resilience.
- partners_withSep 1, 2026
In Sep '26 in China, Chime Biologics and Magic Mirror Biotech enter a strategic partnership to integrate AI, mechanistic modeling, digital twins, and intelligent process optimization into the Chime AI Platform across biologics R&D, process development, and manufacturing.
Chime Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chime Biologics's valuation, stock price, and market status.
Is Chime Biologics a public or private company?
Chime Biologics is a private company.
What is the current stock price of Chime Biologics?
Chime Biologics is a private company, so its shares have no public market price. Caplight tracks Chime Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chime Biologics worth (valuation)?
Valuation information for Chime Biologics is not publicly available.
Can I buy Chime Biologics stock?
Chime Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chime Biologics's last funding round?
Chime Biologics's most recent funding round was Series A Extension on March 25, 2021.
Who are the main investors in Chime Biologics?
Key investors in Chime Biologics include VMS Group.
Will Chime Biologics IPO soon?
No public IPO plans have been announced for Chime Biologics.
How can I track Chime Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Chime Biologics's shares on secondary markets.